Cargando…
Norfloxacin and N-Donor Mixed-Ligand Copper(II) Complexes: Synthesis, Albumin Interaction, and Anti-Trypanosoma cruzi Activity
Copper(II) complexes with the first-generation quinolone antibacterial agent norfloxacin containing a nitrogen donor heterocyclic ligand 2,2′-bipyridine (bipy) or 1,10-phenanthroline (phen) were prepared and characterized by IR, EPR spectra, molar conductivity, and elemental analyses. The experiment...
Autores principales: | Martins, Darliane A., Gouvea, Ligiane R., Muniz, Gabriel S. Vignoli, Louro, Sonia R. W., Batista, Denise da Gama Jaen, Soeiro, Maria de Nazaré C., Teixeira, Letícia R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746275/ https://www.ncbi.nlm.nih.gov/pubmed/26924953 http://dx.doi.org/10.1155/2016/5027404 |
Ejemplares similares
-
The Impact of the CTHRSSVVC Peptide Upon Experimental Models of Trypanosoma cruzi Infection
por: Leite, Gabriela Rodrigues, et al.
Publicado: (2022) -
Combined Treatment of Heterocyclic Analogues and Benznidazole upon Trypanosoma cruzi In Vivo
por: Batista, Denise da Gama Jaén, et al.
Publicado: (2011) -
Efficacy of sertraline against Trypanosoma cruzi: an in vitro and in silico study
por: Ferreira, Daiane Dias, et al.
Publicado: (2018) -
Overexpression of TcNTPDase-1 Gene Increases Infectivity in Mice Infected with Trypanosoma cruzi
por: da Silva-Gomes, Natália Lins, et al.
Publicado: (2022) -
Screening of Potential anti-Trypanosoma cruzi Candidates: In Vitro and In Vivo Studies
por: Soeiro, Maria de Nazaré C, et al.
Publicado: (2011)